WuXi Biologics introduces new platform to boost recombinant protein and plasmid DNA production

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

March 4, 2025 | Tuesday | News
WuXi Biologics Successfully Passes Japan PMDA GMP Inspection Again

WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...

February 28, 2025 | Friday | News
CDMO Live Debuts as BioPharma Manufacturing Sector Approaches $200 Billion

CDMO Live has emerged as the definitive industry gathering, bringing together Europe's leading pharmaceutical outsourcin...

February 26, 2025 | Wednesday | News
WuXi XDC and LigaChem Biosciences expand MoU to accelerate ADC development

China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...

February 25, 2025 | Tuesday | News
Jubilant Biosys strengthens footprint in Europe for Biologics and Antibody Drug Conjugate services

Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, ...

February 13, 2025 | Thursday | News
“China and Asia are already the global leaders of Antibody-drug conjugates”

Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...

February 1, 2025 | Saturday | Opinion
Korea's Lotte Biologics unveils antibody-drug conjugate platform SoluFlex Link

At the 2025 J.P. Morgan Healthcare Conference held recently, now in its 43rd year, South Korea-based Lotte Biologics unv...

January 20, 2025 | Monday | News
Lyndra Therapeutics inks manufacturing services collaboration with Thermo Fisher for long-acting oral therapies

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has announced a s...

January 16, 2025 | Thursday | News
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development in Korea

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has announced&...

January 9, 2025 | Thursday | News
Partnership in China to build new ecosystem for antibody-drug conjugates

Porton Pharma Solutions and Dragon Sail Pharmaceutical (Shanghai) have signed a strategic cooperation agreement in Guili...

December 24, 2024 | Tuesday | News
Japan's Shimadzu develops platform to support gene therapy manufacturing

Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...

December 17, 2024 | Tuesday | News
Hong Kong's Viva Biotech establishes Boston branch, marking another milestone in global expansion

Viva Biotech Holdings Group has announced the official establishment of its new branch in Boston, US. As a glo...

December 11, 2024 | Wednesday | News
VectorBuilder and Sartorius sign strategic cooperation agreement to advance biopharma innovation

VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in l...

November 27, 2024 | Wednesday | News
Korea's Samsung Biologics signs $668 M worth manufacturing deal with European pharma company

Samsung Biologics, a global contract development and manufacturing organisation (CDMO) based in South Korea, has announc...

November 21, 2024 | Thursday | News
Chime Biologics and Waterstone team up to empower ADC development and manufacturing

China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...

November 13, 2024 | Wednesday | News
Lonza expands Bioconjugation capabilities with two additional manufacturing suites in Switzerland

Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has anno...

November 12, 2024 | Tuesday | News
GenScript Biotech sets up new operations and logistics hub in Australia

GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment o...

November 12, 2024 | Tuesday | News
Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...

November 11, 2024 | Monday | News